secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tango Therapeutics, Inc. (TNGX)
CIK:        0001819133
Form:       8-K
Filed at:   2023-08-30T23:59:59+00:00
Accession:  0001193125-23-224253
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Tango Therapeutics director Aaron Davis resigns; John Ketchum appointed to board
--------------------------------------------------------------------------------

- Aaron Davis resigned from board effective Aug 28, 2023; no disagreement with management.
- John Ketchum appointed as Class III director effective Aug 29, 2023; will stand for election at 2024 annual meeting.
- Ketchum receives option for 60,000 shares at $7.19, RSU for 10,000 shares, and $40k annual retainer.
- Ketchum deemed independent under Nasdaq rules; no committee assignments yet.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819133/000119312523224253/0001193125-23-224253-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819133/000119312523224253/d532996d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-224253

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer